By performing dual targeting of each SIK gene combination in 17 AML cell lines, researchers observed a broad AML-specific requirement for SIK2 + SIK3 resembling the pattern of LKB1 dependence with a bias for lines with mixed lineage leukemia fusions. This evidence concerns the gene SIK2 and acute myeloid leukemia.